# Protein Intake Resistance Training Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/protein-intake-resistance-training-meta-analysis-evidence-review
Category: evidence-review
Summary: Protein Intake Resistance Training Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first
Last reviewed: 2026-07-24
Reviewed by: Migaku Evidence Review
# Protein Intake Resistance Training Meta-analysis: What the Evidence Says

## Quick Answer

Protein Intake Resistance Training Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of Physical Exercise with and Without Nutritional Supplementation on Serum Albumin in Older People: A Systematic Review and Meta-Analysis | systematic review | 1 | 2026-05-31 | 10.3390/biom16060817 |
| Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance | narrative review | 3 | 2026-05-29 | 10.3390/nu18111751 |

## What The Sources Report

- These conditions are associated with progressive functional decline, loss of independence, increased use of healthcare services, and a higher risk of mortality, highlighting the need for comprehensive preventive and therapeutic strategies specifically targeting this age group, as well as avoiding large direct costs for governments and public health systems. [Aravena-Sagardia Pablo (2026); evidence level 1]
- Evidence suggests that interventions based on physical exercise and healthy nutrition not only contribute to the maintenance of muscle mass and strength but also modulate key metabolic and inflammatory processes associated with aging. [Aravena-Sagardia Pablo (2026); evidence level 1]
- Randomized clinical trials consistently report mean weight loss ranging from approximately 15% to more than 20% of total body weight, accompanied by improvements in glycemic control, cardiometabolic risk factors, and obesity-related comorbidities. [Zambrano-Villacres Raynier (2026); evidence level 3]
- As a result, pharmacotherapy is increasingly positioned as an important component of contemporary obesity treatment algorithms rather than a secondary or last-line option. [Zambrano-Villacres Raynier (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For protein intake resistance training meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Aravena-Sagardia Pablo (2026). Effects of Physical Exercise with and Without Nutritional Supplementation on Serum Albumin in Older People: A Systematic Review and Meta-Analysis. DOI: 10.3390/biom16060817. PMCID: PMC13297322. PMID: 42352283. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13297322/
- Zambrano-Villacres Raynier (2026). Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance. DOI: 10.3390/nu18111751. PMCID: PMC13258902. PMID: 42280393. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258902/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.